Skip to main content

Table 2 Lack of evidence for intrathecal IgG synthesis in 17 CSF samples from 15

From: MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin

Sample no. MOG-IgG titer, serum MOG-IgG titer, CSF MOG-IgG titer required for AI >4 Evidence for intrathecal MOG-IgG synthesis
#1 1:10240 1:64 1:925.7 No
#2 1:2560 1:4 1:25.6 No
#3 1:320 1:2 1:2.3 No
#4 1:10240 1:16 1:152.5 No
#5 1:640 1:4 1:9 No
#6 1:2560 1:4 1:30.7 No
#7 1:10240 1:16 1:176.1 No
#8 1:2560 1:2 1:19.5 No
#9 1:320 1:2 1:3.6 No
#10 1:1280 1:2 1:9.4 No
#11 1:2560 1:4 1:25 No
#12 1:320 1:4 1:6 No
#13a 1:1280 NEG 1:17.4 No
#14 1:320 NEG 1:3.7 No
#15 1:1280 NEG 1:10.2 No
#16 1:160 NEG 1:2.1 No
#17b 1:1280 NEG 1:10.2 No
  1. MOG-IgG seropositive patients with ON and/or myelitis. NEG negative. aFollow-up to sample #1; b follow-up to sample #2